This is an observational, retrospective study focused on differences of time-in-range and glycemic variability between a cohort of patients with both type 1 diabetes and celiac disease, and a cohort of patients with only type 1 diabetes.
The study design provides for 2 cohorts of pediatric and adolescent patients using the continuous glycemic monitoring sensor. Cohort A consists of patients with type 1 diabetes and celiace disease, while cohort B consists of patients with only type 1 diabetes. The primary aim of the study is to assess whether cohort A patients can achieve the same metabolic control and glycemic variability goals (expressed as Time-In-Range and glycemic Variability Coefficient) as cohort B patients. The secondary aims are: assessing differences in Time-In-Range and glycemic Variability Coefficient between cohort A patients treated with multidaily injections, and those treated with continuous subcutaneous insulin infusion; assessing differences on total daily insulinic intake between cohort A and cohort B.
Study Type
OBSERVATIONAL
Enrollment
200
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
Differences on metabolic control between cohort A and B
time-in-range
Time frame: in the 14 days prior to the most recent outpatient visit between February 2019 and February 2020
Differences on glycemic variability between cohort A and B
glycemic variability coefficient
Time frame: in the 14 days prior to the most recent outpatient visit between February 2019 and February 2020
Differences on metabolic control between patients on different therapeutic regimen
time-in-range
Time frame: in the 14 days prior to the most recent outpatient visit between February 2019 and February 2020
Differences on glycemic variability between patients on different therapeutic regimen
glycemic variability coefficient
Time frame: in the 14 days prior to the most recent outpatient visit between February 2019 and February 2020
Differences on total daily insulinic intake between cohort A and B
U/kg/die
Time frame: in the 14 days prior to the most recent outpatient visit between February 2019 and February 2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.